Radiolabelled BLyS

Drug Profile

Radiolabelled BLyS

Alternative Names: Ardenermin-I-131; Iodine-131 BLyS; Iodine-131 labeled B-Lymphocyte Stimulator; LR131; LymphoRad-131

Latest Information Update: 06 Mar 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Human Genome Sciences
  • Class Antineoplastics; Radiopharmaceuticals
  • Mechanism of Action Apoptosis stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Multiple myeloma; Non-Hodgkin's lymphoma

Most Recent Events

  • 06 Mar 2006 Discontinued - Phase-I for Multiple myeloma in Canada (unspecified route)
  • 06 Mar 2006 Discontinued - Phase-I for Multiple myeloma in USA (unspecified route)
  • 06 Mar 2006 Discontinued - Phase-I for Non-Hodgkin's lymphoma in Canada (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top